COYA Projected Dividend Yield
Coya Therapeutics Inc ( NASDAQ : COYA )Coya Therapeutics is a clinical-stage biotechnology company focused on developing therapies to improve the function of regulatory T cells ("Tregs"). Tregs consist of CD4+CD25high hFOXP3+ cells, which are a subpopulation of T-lymphocytes. Co. has product candidate pipeline that includes both ex vivo and in vivo therapeutic approaches intended to restore the suppressive and immunomodulatory functions of Tregs. Co.'s product candidate pipeline is based on: Treg-enhancing biologics; Treg-derived exosomes (a sac-like structures that are formed inside a cell and contain some of the cell's proteins, lipids, and nucleic acids); and autologous (obtained from the same individual) Treg cell therapy. 20 YEAR PERFORMANCE RESULTS |
COYA Dividend History Detail COYA Dividend News COYA Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |